Sage Therapeutics, Inc. Contracts & Agreements

79 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
Biotechnology
2014
Amendment to Amended and Restated 2016 Inducement Equity Plan
Sage Therapeutics, Inc.
2024
2024 Equity Incentive Plan
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
2024
Form of Option Agreement under the 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
2024
Form of Restricted Stock Unit Agreement under the 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
2024
Form of Non-Employee Director Option Agreement under the 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
2024
Non-Employee Director Compensation Program, adopted June 10, 2024
Compensation Agreements
Sage Therapeutics, Inc.
2024
Amendment to Amended and Restated 2016 Inducement Equity Plan
Sage Therapeutics, Inc.
2024
Separation Agreement between the Registrant and Albert J. Robichaud, Ph.D., dated September 15, 2023
Separation Agreements
Sage Therapeutics, Inc.
2023
Master Consulting Agreement and Statement of Work between the Registrant and Albert J. Robichaud, Ph.D., dated September 15, 2023
Consulting Agreements
Sage Therapeutics, Inc.
2023
Sales Agreement, dated as of November 7, 2023, by and between the Company and Cowen and Company, LLC
Sales Agreements
Sage Therapeutics, Inc.
2023
2014 Employee Stock Purchase Plan, as amended
Stock Agreements
Sage Therapeutics, Inc.
2023
Supply Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated December 13, 2012, as amended August 21, 2013 and April 30, 2014
Supply Agreements
Sage Therapeutics, Inc.
2023
Amendment No. 3 to Supply Agreement, by and between the Registrant and CyDex Pharmaceuticals, Inc., dated September 25, 2015
Supply Agreements
Sage Therapeutics, Inc.
2023
Commercial License Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated August 21, 2013, as amended April 30, 2014
License Agreements
Sage Therapeutics, Inc.
2023
Non-Exclusive License Agreement by and between the Registrant and the Regents of University of California, dated October 23, 2013, as amended May 14, 2014
License Agreements
Sage Therapeutics, Inc.
2023
Exclusive License Agreement by and between the Registrant and Washington University, dated November 11, 2013
License Agreements
Sage Therapeutics, Inc.
2023
2014 Employee Stock Purchase Plan, as amended
Stock Agreements
Sage Therapeutics, Inc.
2022
Amended and Restated Non-Employee Director Compensation Policy, dated April 8, 2022
Compensation Agreements
Sage Therapeutics, Inc.
Biotechnology
2022
Offer Letter by and between the Registrant and Christopher Benecchi, dated September 13, 2021
Sage Therapeutics, Inc.
2021
Side Letter to Biogen Collaboration and License Agreement, by and among the Registrant, Biogen MA Inc. and Biogen International GmbH, dated October 21, 2021
Collaboration Agreements
Sage Therapeutics, Inc.
2021
Amendment No. 1 to Exclusive License Agreement, by and between the Registrant and Washington University, dated as of July 13, 2021
License Agreements
Sage Therapeutics, Inc.
Biotechnology
2021
Severance and Change in Control Agreement between the Registrant and Christopher Benecchi, dated September 13, 2021
Change of Control Agreements
Sage Therapeutics, Inc.
2021
Separation Agreement, by and between the Registrant and Michael Cloonan, dated March 12, 2021
Separation Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2021
Form of Performance-Based Restricted Stock Unit Award Agreement Under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
Biotechnology
2020
Description of Securities
Sage Therapeutics, Inc.
2020
Eighth Amendment to Lease by and between ARE-MA Region No. 38, LLC and the Registrant, dated March 29, 2019
Lease Agreements
Sage Therapeutics, Inc.
2019
Underwriting Agreement, dated as of February 25, 2019, by and among Sage Therapeutics, Inc. and Goldman Sachs & Co. LLC. and J.P. Morgan Securities LLC
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2019
Amended and Restated 2016 Inducement Equity Plan and forms of agreements thereunder, as amended and restated on September 20, 2018
Sage Therapeutics, Inc.
Biotechnology
DE
2018
Amended and Restated Non-Employee Director Compensation Policy, dated as of September 20, 2018
Compensation Agreements
Sage Therapeutics, Inc.
Biotechnology
2018
Seventh Amendment to Lease by and between ARE-MA Region No. 38, LLC and the Registrant, dated October 23, 2018
Lease Agreements
Sage Therapeutics, Inc.
Biotechnology
2018
First Amendment to Lease by and between CLPF-Cambridge Science Center LLC and the Registrant dated April 4, 2018
Lease Agreements
Sage Therapeutics, Inc.
2018
Amended and Restated Non-Employee Director Compensation Plan, dated as of March 30, 2018
Compensation Agreements
Sage Therapeutics, Inc.
2018
Underwriting Agreement, dated as of February 8, 2018, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as...
Underwriting Agreements
Sage Therapeutics, Inc.
2018
Underwriting Agreement, dated as of November 14, 2017, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as...
Underwriting Agreements
Sage Therapeutics, Inc.
2017
Sage Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Sage Therapeutics, Inc.
Biotechnology
2017
Sixth Amendment to Lease by and between ARE-MA Region No. 38, LLC and the Registrant dated May 8, 2017
Lease Agreements
Sage Therapeutics, Inc.
Biotechnology
2017
2014 Employee Stock Purchase Plan
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2017
Offer letter by and between the Registrant and Michael Cloonan, dated March 21, 2017
Sage Therapeutics, Inc.
2017
Severance and Change in Control Agreement between the Registrant and Michael Cloonan, dated March 21, 2017
Change of Control Agreements
Sage Therapeutics, Inc.
2017
SAGE Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Sage Therapeutics, Inc.
2017
SAGETHERAPEUTICS, INC. 4,402,515 Shares of Common Stock Underwriting Agreement (thisAgreement)
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2016
THE CAMBRIDGE SCIENCE CENTER 245FIRST STREET CAMBRIDGE, MASSACHUSETTS 02142 LEASE SUMMARY SHEET
Lease Agreements
Sage Therapeutics, Inc.
2016
THE CAMBRIDGE SCIENCE CENTER 245FIRST STREET CAMBRIDGE, MASSACHUSETTS 02142 LEASE SUMMARY SHEET
Lease Agreements
Sage Therapeutics, Inc.
Biotechnology
2016
Sage Therapeutics
Sage Therapeutics, Inc.
Biotechnology
2016
FIFTH AMENDMENT TO LEASE
Lease Agreements
Sage Therapeutics, Inc.
Biotechnology
2016
SAGETHERAPEUTICS, INC. 3,157,894 Shares of Common Stock Underwriting Agreement (thisAgreement)
Underwriting Agreements
Sage Therapeutics, Inc.
2016
FOURTH AMENDMENT TO LEASE
Lease Agreements
Sage Therapeutics, Inc.
2015
THIRD AMENDMENT TO LEASE
Lease Agreements
Sage Therapeutics, Inc.
2015
AMENDMENT NO. 3 TO SUPPLY AGREEMENT
Supply Agreements
Sage Therapeutics, Inc.
2015
AMENDED AND RESTATED COMMERCIAL LICENSE AGREEMENT
License Agreements
Sage Therapeutics, Inc.
2015
EXCLUSIVE LICENSE AGREEMENT BETWEEN SAGETHERAPEUTICS, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR NEUROSTEROIDS ANDTHEIR USE IN SEIZURES AND TRAUMATIC BRAIN INJURY UC...
License Agreements
Sage Therapeutics, Inc.
2015
SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement)
Underwriting Agreements
Sage Therapeutics, Inc.
2015
SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2015
SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
Sage Therapeutics, Inc.
2015
SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
Sage Therapeutics, Inc.
2015
SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2015
SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
Sage Therapeutics, Inc.
2015
SAGE THERAPEUTICS, INC. 2014 STOCK OPTION AND INCENTIVE PLAN
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
2014
SAGE THERAPEUTICS, INC. 2011 STOCK OPTION AND GRANT PLAN
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 EXCLUSIVE...
Exchange Agreements
Sage Therapeutics, Inc.
Biotechnology
WA
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 COMMERCIAL...
Exchange Agreements
Sage Therapeutics, Inc.
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 Non-Exclusive...
Exchange Agreements
Sage Therapeutics, Inc.
2014
LEASE AGREEMENT
Lease Agreements
Sage Therapeutics, Inc.
Biotechnology
2014
Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
2014
Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
2014
SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement
Non-Competition Agreements
Sage Therapeutics, Inc.
2014
SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement
Non-Competition Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2014
SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement
Non-Competition Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2014
SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement
Non-Competition Agreements
Sage Therapeutics, Inc.
2014
SAGE THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN
Bonus & Incentive Agreements
Sage Therapeutics, Inc.
Biotechnology
2014
SAGE THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT
Indemnification Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2014
SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement)
Underwriting Agreements
Sage Therapeutics, Inc.
Biotechnology
NY
2014
SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Sage Therapeutics, Inc.
Biotechnology
MA
2014
SAGE THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT
Indemnification Agreements
Sage Therapeutics, Inc.
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 SUPPLY AGREEMENT
Exchange Agreements
Sage Therapeutics, Inc.
Biotechnology
CA
2014
SAGE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Sage Therapeutics, Inc.
Biotechnology
DE
2014
P ###-###-#### F ###-###-#### 215 First Street, Cambridge, MA 02142
Sage Therapeutics, Inc.
Biotechnology
2014
SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
Sage Therapeutics, Inc.
2014